Figure 3.

Success rates and 95% CIs for individual studies in the three treatment groups. The vertical lines give the mean success rates (and 95% confidence bands; shaded areas) for each group, taking into account within-group variation. We also provide the numbers cured and total infected for each study and the duration of follow-up in days. There were significant differences in cure proportions between ABL and SABX (OR, 2.08; 95% CI, 1.25 to 3.45; P<0.01) and between GWX and SABX (OR, 2.88; 95% CI, 1.82 to 4.55; P<0.001). The difference between GWX and ABL was not significant (OR, 1.39; 95% CI, 0.78 to 2.46; P=0.27).